Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan and Amlodipine in Hypertension
NCT00409760Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2003
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan, amlodipine in hypertension (HTN), sponsored by Novartis. Started Jan 2003; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00409760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409760.